Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 70 Thoracic 12 Head & Neck 9 Gynecologic 4 CNS 3 Breast 3 Lymphoid 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Other neoplasm 1 NET 1 Endocrine 1

Conditions

Interventions

Doxorubicin 25 Cyclophosphamide 24 pembrolizumab 20 Specimen Handling 19 Temozolomide 16 Magnetic Resonance Spectroscopy 15 Surgical Procedures, Operative 14 Radiotherapy 13 Blood Specimen Collection 13 Biopsy 13 atezolizumab 12 Gemcitabine 12 fludarabine 11 Vincristine 11 Ifosfamide 11 X-Rays 8 Trabectedin 8 Nivolumab 8 Irinotecan 8 Imatinib Mesylate 8 Drug Therapy 8 cabozantinib 7 Surveys and Questionnaires 7 Radiation 7 liposomal doxorubicin 5 abemaciclib 5 Sunitinib 5 Standard of Care 5 Radiation Dose Hypofractionation 5 Dactinomycin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × sintilimab × Sarcoma × Clear all

NCT04589754 2024-01-02

Adriamycin and Ifosfamide Combined With Sintilimab

Sun Yat-sen University

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡